These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Skin care products: What do they promise, what do they deliver. Surber C; Kottner J J Tissue Viability; 2017 Feb; 26(1):29-36. PubMed ID: 27090800 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured novel carrier for topical application. Guglielmini G Clin Dermatol; 2008; 26(4):341-6. PubMed ID: 18691513 [TBL] [Abstract][Full Text] [Related]
9. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Förster M; Bolzinger MA; Fessi H; Briançon S Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302 [TBL] [Abstract][Full Text] [Related]
14. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? Harvey PW; Darbre P J Appl Toxicol; 2004; 24(3):167-76. PubMed ID: 15211609 [TBL] [Abstract][Full Text] [Related]
16. Skin care products and subtle data manipulation. Wolf R; Orion E; Davidovici B Clin Dermatol; 2007; 25(2):222-4. PubMed ID: 17350502 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of bioavailability by lowering of fat content in topical formulations. Wirén K; Frithiof H; Sjöqvist C; Lodén M Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336 [TBL] [Abstract][Full Text] [Related]
20. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics. Lodén M; Ungerth L; Serup J Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]